Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Neoplasms Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04753879
What this trial is testing

Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.

Who this might be right for
Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 38
Testing effectiveness (Phase 2)Looking for participantsNCT06584227
What this trial is testing

Adebrelimab and Chidamide for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Adult
Liu Xiufeng 45
Early research (Phase 1)Active Not RecruitingNCT05143970
What this trial is testing

First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors

Who this might be right for
Metastatic CancerMetastatic Breast CancerMetastatic Pancreatic Cancer+6 more
Institut Paoli-Calmettes 27
Not applicableActive Not RecruitingNCT03460769
What this trial is testing

Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)

Who this might be right for
Pancreatic CancerChronic PancreatitisDiabetes Mellitus Type 3c
M.D. Anderson Cancer Center 775
Early research (Phase 1)Study completedNCT05440942
What this trial is testing

Combined MEK, STAT3 and PD-1 Inhibition in Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Peter Hosein, MD 28
Early research (Phase 1)Study completedNCT02155088
What this trial is testing

BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute 15
Testing effectiveness (Phase 2)Study completedNCT00967603
What this trial is testing

Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
IRCCS San Raffaele 56
Not applicableLooking for participantsNCT06375473
What this trial is testing

Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
Peking Union Medical College Hospital 3,000
Post-approval studies (Phase 4)UnknownNCT04269369
What this trial is testing

Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients

Who this might be right for
Colon CancerStomach TumorAnal Tumor+2 more
Jessa Hospital 250
Testing effectiveness (Phase 2)Study completedNCT02074046
What this trial is testing

Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer

Who this might be right for
Neoplasms, Pancreas
Fuda Cancer Hospital, Guangzhou 40
Not applicableStudy completedNCT03133286
What this trial is testing

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)

Who this might be right for
Radiation TherapyCancerCancer of Anus+16 more
DxTerity Diagnostics 16
Not applicableNot Yet RecruitingNCT06195904
What this trial is testing

Genomic Profiling of Pancreatic Cystic Tumors

Who this might be right for
Pancreatic Cyst
Samsung Medical Center 250
Not applicableStudy completedNCT07592338
What this trial is testing

Agreement Between Large Language Model-Generated Treatment Recommendations With Guideline-Based and Tumor Board Decisions in Gastrointestinal Cancer

Who this might be right for
Gastric Cancer (GC)Colorectal CancerPancreatic Cancer
Medizinische Hochschule Brandenburg Theodor Fontane 30
Not applicableStudy completedNCT04348084
What this trial is testing

Oncologic Impact of Pancreatic Fistula

Who this might be right for
PDAC of the Body and the Tail of the PancreasCR- POPF
University Hospital, Montpellier 382
Early research (Phase 1)Study completedNCT01188785
What this trial is testing

Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Non-operable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic Cancer
Silenseed Ltd 15
Not applicableUnknownNCT01665625
What this trial is testing

Regional Versus Systemic Chemotherapy in the Treatment of Unresectable Pancreatic Cancer

Who this might be right for
Unresectable Pancreatic Cancer
Air Force Military Medical University, China 90
Large-scale testing (Phase 3)Study completedNCT00003049
What this trial is testing

Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Mayo Clinic 100
Not applicableLooking for participantsNCT06698458
What this trial is testing

Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic AdenocarcinomaMetastatic Pancreatic Cancer
Alpha Tau Medical LTD. 50
Early research (Phase 1)Study completedNCT01478685
What this trial is testing

CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Urinary Bladder NeoplasmsCarcinoma, Transitional CellOvarian Neoplasms+5 more
Celgene 169
Early research (Phase 1)WithdrawnNCT02048943
What this trial is testing

Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer

Who this might be right for
Duct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic Cancer+2 more
Roswell Park Cancer Institute
Next Page